The Defence and Security Accelerator (DASA) recently sought to identify novel Point of Care (PoC) diagnostic devices to aid the diagnosis of individuals exposed to biological or chemical agents. DASA are interested to hear from organisations developing genuinely novel solutions in this field.
Throughout the history of armed conflict, Disease and Non-Battle Injury (DNBI), particularly infection, has caused significant morbidity and mortality among deployed forces. There is a need for rapid diagnostic technologies for affected individuals and personnel involved in response and recovery work.
Technologies that enable rapid diagnosis of individuals exposed to biological or chemical agents are currently limited and can be time-consuming, resource intensive, provide a limited identification capability and frequently rely on reach back to laboratory facilities. This limits the clinical usefulness of the results generated, and PoC diagnostic devices represent an attractive solution to this problem. These may be used in austere environments or may also be used in a doctor’s surgery or at the patient’s bedside. Regardless of location it is anticipated that such devices will provide quick feedback and impact significantly on the trajectory of patient care.
DASA are interested to hear from organisations developing truly novel techniques and tools in this field. To discuss this with your nearest Innovation Partner, contact firstname.lastname@example.org or 01980 950000 option 3.